Jianrong Zhu

Title: Jianrong Zhu and a Casein Kinase 1ε Inhibitor Crystal Form.

Introduction

Jianrong Zhu is an inventor associated with Hangzhou, China, and Hangzhou Healzen Therapeutics Co., Ltd. His disclosed work concerns a crystal form of a casein kinase 1ε inhibitor, including its preparation and potential use.

Latest Patents

The patent, “Crystal Form of Casein Kinase 1ε Inhibitor and Preparation Method and Use Thereof,” describes a crystal form of the methanesulfonate salt of a specific inhibitor compound. The disclosure reports that the crystal form has good water solubility and oral absorption, and proposes its use in treating malignant tumors and autoimmune diseases that may benefit from inhibiting casein kinase 1ε activity. Zhu is associated with 1 patent in the information provided.

Career Highlights

The available information links Zhu’s patent work to Hangzhou Healzen Therapeutics Co., Ltd. The disclosed invention focuses on the compound’s crystal form and its preparation, properties, and potential therapeutic applications.

Collaborations

Xinglu Zhou and Xingguo Liu are identified as Zhu’s coworkers. The provided information does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Jianrong Zhu’s disclosed patent work centers on a casein kinase 1ε inhibitor crystal form with reported solubility and oral absorption properties, and potential applications in cancer and autoimmune disease treatment.